世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2015年
5期
699-702
,共4页
肠易激综合征%腹泻型%调肝理脾法
腸易激綜閤徵%腹瀉型%調肝理脾法
장역격종합정%복사형%조간리비법
Irritable bowel syndrome%Diarrhea%Regulating liver and spleen method
目的：观察调肝理脾法治疗腹泻型肠易激综合征（ IBS－D）的临床疗效。方法：97例IBS－D患者随机分为调肝理脾中药组和匹维溴铵西药组，分别给予调肝理脾方及匹维溴铵治疗。疗程均为4周，疗程结束后随访3个月，观察症状疗效。结果：治疗2周后、治疗4周后、治疗结束后第1个月及第3个月随访时，2组总症状积分改善明显优于治疗前，差异有统计学意义（ P＜0．05）；治疗4周后，2组病例IBS症状积分减少值，调肝理脾组优于匹维溴铵组，差异有统计学意义（ P＜0．05）；治疗4周后，调肝理脾组总有效率为92．2％，匹维溴铵组为69．6％，调肝理脾组优于匹维溴铵组，差异具有统计学意义（ P＜0．05）；在改善排便次数和大便性状等主要症状方面调肝理脾组要优于匹维溴铵组，差异有统计学意义（ P＜0．05）。结论：应用调肝理脾方随证加减治疗IBS－D具有较好的临床疗效。
目的：觀察調肝理脾法治療腹瀉型腸易激綜閤徵（ IBS－D）的臨床療效。方法：97例IBS－D患者隨機分為調肝理脾中藥組和匹維溴銨西藥組，分彆給予調肝理脾方及匹維溴銨治療。療程均為4週，療程結束後隨訪3箇月，觀察癥狀療效。結果：治療2週後、治療4週後、治療結束後第1箇月及第3箇月隨訪時，2組總癥狀積分改善明顯優于治療前，差異有統計學意義（ P＜0．05）；治療4週後，2組病例IBS癥狀積分減少值，調肝理脾組優于匹維溴銨組，差異有統計學意義（ P＜0．05）；治療4週後，調肝理脾組總有效率為92．2％，匹維溴銨組為69．6％，調肝理脾組優于匹維溴銨組，差異具有統計學意義（ P＜0．05）；在改善排便次數和大便性狀等主要癥狀方麵調肝理脾組要優于匹維溴銨組，差異有統計學意義（ P＜0．05）。結論：應用調肝理脾方隨證加減治療IBS－D具有較好的臨床療效。
목적：관찰조간리비법치료복사형장역격종합정（ IBS－D）적림상료효。방법：97례IBS－D환자수궤분위조간리비중약조화필유추안서약조，분별급여조간리비방급필유추안치료。료정균위4주，료정결속후수방3개월，관찰증상료효。결과：치료2주후、치료4주후、치료결속후제1개월급제3개월수방시，2조총증상적분개선명현우우치료전，차이유통계학의의（ P＜0．05）；치료4주후，2조병례IBS증상적분감소치，조간리비조우우필유추안조，차이유통계학의의（ P＜0．05）；치료4주후，조간리비조총유효솔위92．2％，필유추안조위69．6％，조간리비조우우필유추안조，차이구유통계학의의（ P＜0．05）；재개선배편차수화대편성상등주요증상방면조간리비조요우우필유추안조，차이유통계학의의（ P＜0．05）。결론：응용조간리비방수증가감치료IBS－D구유교호적림상료효。
Objective:To observe the clinical efficacy of the method of regulating liver and spleen on treating irritable bowel syn -drome of diarrhea pattern .Methods:A total of 97 IBS-D patients were randomly divided into two groups .One group received tradi-tional Chinese medicine treatment which has effect of regulating liver and spleen; and the other group received pinaverium bro-mide.Both groups received the treatment for 4 weeks.We followed up the patients for 3 months after treatment to observe the symptoms and the curative effect .Results: The symptoms of both groups showed obvious improvement than before the treatment when it was observed after 2 weeks and 4 weeks of treatment , and 1 month and 3 months after treatment .There were statistical differences ( P<0.05 ) .After 4 weeks of treatment , the symptom reduction value of regulating liver and spleen group was better than that of pinaverium bromide group with statistically significant difference ( P<0.05 );the total effectiveness of the regulating liver and spleen group was 92 .2%and pinaverium bromide group was 69 .6%, it indicated that regulating liver and spleen group was better than the pinaverium bromide group and the difference was statistically significant ( P<0.05 ) .In the respect of impro-ving the major symptoms such as the number of defecation and character of stool , the regulating liver and spleen group was superior than pinaverium bromide group , and the difference was statistically significant ( P<0.05 ) .Conclusion:The prescription of regu-lating liver and spleen has a good clinical curative effect on treating IBS-D.
